Skip to main content
Clinical Trials/NCT01277055
NCT01277055
Unknown
Not Applicable

MRI Perfusion Imaging at 3T With TX Parallel RF Technology to Identify Myocardial Ischemia Compared to Invasive FFR Measurements

Heart Center Bogenhausen1 site in 1 country150 target enrollmentJanuary 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Perfusion Imaging
Sponsor
Heart Center Bogenhausen
Enrollment
150
Locations
1
Last Updated
15 years ago

Overview

Brief Summary

Coronary artery disease (CAD) has a great significance concerning prevalence and mortality in the western world. It is usually diagnosed by catheterization and coronary arteries are visually assessed by the examiner. Thus having a great spectrum of interobserver differences, especially when it comes to intermediate lesions. The gold standard to assess the haemodynamic significance is the measurement of the myocardial fractional flow reserve (FFR). The FAME-study (Tonino, De Bruyne et al. 2009) was able o show that additional FFR- measurements in patients with intermediate lesions could significantly reduce stent implementation and consequently mortality. However this method is not used in daily routine and is available only in a fraction of catheter labs worldwide. Taking this into account decision finding especially in intermediate lesions remains difficult.

One major step to simplify the invasive approach concerning intermediate lesions would be to establish a non-invasive procedures which localizes the coronary vessel to intervene ahead catheterization.

Do to steady technical development cardiac MRI has become a powerful tool which is able to determine myocardial vitality, perfusion and function. In particular the new generation of 3 Tesla multi transmit MR with its higher field strength and better spatial resolution seems to be able to show first pass myocardial perfusion more precise. With this new technology prefixed to cardiac catheterization clinical relevant information can be made accessible and thus reduce the number of unnecessary implemented stents.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
TBD
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Heart Center Bogenhausen

Eligibility Criteria

Inclusion Criteria

  • intermediate lesion defined by myocardial fractional flow reserve measurement
  • age \> 18 years

Exclusion Criteria

  • pregnancy
  • contraindication with adenosin, contrast agents or MR-Scaning
  • severe renal dysfunktion
  • instable patient(e.g. acute myocardial infarction)

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials